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Phenotyping of Host−Pathogen Interactions in Mice
Andreas Lengeling, Werner Müller, and Rudi Balling
8.1
Introduction
Infectious diseases are still a major cause of morbidity and mortality worldwide.
One of the major challenges in contemporary infection research is the development
of suitable animal models to further advance our understanding of host−pathogen
interactions. There is an urgent need to better understand (1) the strategies used
by pathogens to evade the host immune response; and (2) the mechanisms that the
host immune system employs to fight off infectious agents. This is a prerequisite
for improving the current prevention and therapeutic strategies that are used in the
battle against infectious diseases.
Susceptibility or resistance of the host to infection is determined by a complex in-
terplay of environmental, host, and pathogen factors. In the past, our approaches to
understanding infectious diseases focused mainly on the study of either individual
environmental or pathogen related factors while the role of the host was limited to
studies on pathogenesis and adaptive immune responses. A few years ago this
changed and now more attention is directed towards analyzing the contribution of
host genetics to the process of infection. In addition, our knowledge of the mecha-
nisms of natural or innate immunity has been largely extended mainly due to
genetic studies in model organisms [1−4]. The mouse as a genetically tractable
mammal has played a pivotal role in defining new pathways and gene functions
that are important for host defense. A crucial requirement for the genetic dissection
of the host immune response to pathogens in mice is the development of robust
and standardized phenotyping assays [5]. Without standardization and comprehen-
sive phenotyping it is not possible to identify relationships between genes and
phenotypes and thus to discover new gene functions.
After giving a brief summary of the history of approaches that have been used in
mice to analyze host defenses we will shortly review how these studies helped to
improve our understanding of the mechanisms of infection susceptibility in man.
We will give a few examples of how mouse genetics has facilitated the identification
of critical host proteins that are involved in immune defense. It is impossible to
adequately review all of the work that has been carried out using different classes of
pathogens in mice. Therefore, we will focus on mouse models of bacterial infec-
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tion, which are also under investigation in our laboratories and at our research
center. For further reading on mouse models of viral and parasitic infection, we can
recommend some of the excellent reviews that have been published recently [6−8].
8.2
Looking Back and Forward: History and State-of-the-Art of Mouse Infection
Phenotyping and Studies of Genetic Infection Susceptibility
The influence of genetic factors on resistance and susceptibility to bacterial infec-
tion in the mouse were first analyzed systematically in the early work of Leslie Web-
ster at the Rockefeller Institute for Medical Research in New York [9, 10]. In fact,
back in the early 1930 s, he was the first to establish what is today called “baseline-
data” for different inbred strains of mice. He started to develop a mouse model of
human typhoid fever by infecting mice orally with Bacillus enteritidis [9], now
known as Salmonella enterica Serovar Typhimurium (or sometimes as the short-
ened but incorrect form, Salmonella typhimurium). He standardized many critical
parameters of his experiments and thereby pioneered the reproducible investiga-
tion of host responses in animal models under controlled conditions (e. g. tempera-
ture, diet, age, weight and sex of mice [10]). Webster defined new standards of mice
handling and housing by paying careful attention to the monitoring and main-
tenance of hygiene conditions in his mouse colonies [9]. He analyzed the influence
of different routes of Salmonella inoculation (e. g. oral, intravenous, and subcu-
taneous application of the pathogen) on the outcome of infection and thoroughly
investigated parameters such as dose of infection and kinetics of survival over time
[10]. His studies enabled him to set up a mouse typhoid infection model by selective
inbreeding of high-mortality and low-mortality lines of mice. He started to explore
the heritability of infection susceptibility and demonstrated that “genetic factors”
segregated in the backcross progenies of his newly established salmonella-resistant
and -sensitive mouse strains. He concluded for the first time that “inherited com-
ponents of resistance affect the response of the host to infection” [9]. This conclu-
sion was possible because Webster tried to minimize the effects of interfering en-
vironmental factors. In particular, he worked with mice that were free from pre-ex-
isting infections with Salmonella or other pathogens, conditions to which not many
of his colleagues paid attention to at that time. Today, a “specific pathogen-free
(SPF)” standard in mouse breeding facilities is still an important requirement for
any immunological study. Below we will discuss the impact that hygiene conditions
can have on the outcome of infection challenge experiments and the standards nec-
essary for the analysis of immune responses in mice under infection challenge con-
ditions (see Sections 8.4 and 8.5.4).
Another well-established model is murine listeriosis. It has been studied for the
past four decades to examine basic aspects of innate and acquired cellular immu-
nity. Listeriosis is caused by Listeria monocytogenes which has emerged as a remark-
ably tractable pathogen with which to investigate basic aspects of intracellular
pathogenesis. Infection challenge experiments with L. monocytogenes have been
proven to be one of the most successful experimental models in history for defining
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mechanisms that underlie immunity and host defense to infectious diseases. Fun-
damental concepts in immunology, such as macrophage activation [11, 12], the role
of CD4+- and CD8+-T cells [13], major histocompatibility (MHC) restriction [14],
adoptive transfer of T cell-mediated immunity [15], and the function of cytokines
(for a detailed review see [16]), were derived from or further explored in this model.
L. monocytogenes is a facultative intracellular, Gram-positive bacterium that causes
sepsis and meningitis in immunocompromised patients and devastating maternal/
fetal infection in pregnantwomen. In 1962,GeorgeMackaness described the first ex-
perimental model of listeriosis in mice [11]. Mackaness was interested in the im-
munological basis of non-humoral and acquired resistance to infection and investi-
gated the pathogenesis of listeriosis in mice. He established assays for the examina-
tion of macrophage responses to L. monocytogenes in mice by isolating the cells from
the peritoneal cavity and infecting them with Listeria in vitro. His readout assays for
the bactericidal activity of the macrophages were quite simple and effective; he
counted lytic plaques in cellular monolayers and enumerated ingested bacteria in
macrophages by microscopy after staining with May−Grunwald−Giemsa [11]. More
importantly, he developed a delayed-type hypersensitivity assay for Listeria by inject-
ing a sterile filtrate of L.monocytogenes into the hind footpads of previously sub-lethal
infected mice and afterwards examined the swelling of the footpads over time. This
technique enabled him tomonitor the response ofmice to re-infectionwith L.mono-
cytogenes [11] and it was one of the crucial methods that allowed him to define the
general basis of cellular immunity to pathogens. By combining the delayed-type hy-
persensitivity assay with the transfer of lymphoid spleen cells from Listeria-infected
mice into naïvemice, he was able to demonstrate that the transferred cells conferred
protection against subsequent L. monocytogenes infection [15]. This was the starting
point for the investigation of mechanisms of cellular immunity.
The genetic control of immune responses to infection with L. monocytogenes in
different inbred strains of mice soon became a subject of intensive studies [17−19].
C57BL/6J, C57BL/10Sn, and B10.A mice were reported to be resistant to L. monocy-
togenes infection, whereas A/J, BALB/c, CBA/J, C3H/HeJ, DBA/1J and DBA/2J
mice have been shown to be sensitive to infection with this pathogen [17, 18]. In
Emil Skamene’s laboratory genetic linkage studies using the AXB and BXA recom-
binant inbred (RI) lines of mice that were established from A/J and C57BL/6J
parental strains of mice led to the mapping of two loci involved in the control of
bacterial growth in the group of the susceptible RI strains [20]. Co-segregation with
alleles at the hemolytic complement (Hc) locus on mouse chromosome 2 suggested
early on that a deficiency in complement factor C5 was responsible for the suscepti-
bility of the A/J parental strain. This was further supported by the observation that
A/J mice were protected from Listeria infection when they were reconstituted with
C5-rich serum from the C5+ B10.D2/nSN strain [20]. More recently, the genetic sus-
ceptibility to L. monocytogenes infection in C57BL/6ByJ and BALB/cByJ mice was
further refined by the mapping of two loci controlling systemic infection to mouse
chromosomes 5 and 13 [21].
Today, the use of RI strains has again become very popular in the study of the
complex genetics of pathogen defense. A powerful new genetic tool will be
developed within the next years that will probably allow a new roadmap of interac-
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tions between genes and polygenic networks to be defined. The complex trait con-
sortium will establish the 1K-Collaborative-Cross (1KCC) of RI strains. It is planned
to generate about 1000 new RI strains of mice from eight different parental inbred
strains that can be used for phenotyping and high-resolution trait mapping [22].
One of the main attractions of the 1KCC system is the possibility of combining
traditional genetic methods with novel systems-biology approaches.
The identification of the Lsh/Ity/Bcg locus is an impressive early example of the
positional cloning of a single host gene in the mouse that is responsible for the sus-
ceptibility of different inbred strains to taxonomically unrelated intracellular patho-
gens. This locus mediates resistance of mice to Leishmania donavani (Lsh locus),
Salmonella enterica Serovar Typhimurium (Ity locus), and to a number of different
Mycobacterial species such as Mycobacterium bovis BCG (Bcg locus). Genetic sus-
ceptibility to these pathogens is caused by a mutation in the Slc11a1 gene (pre-
viously known as natural resistance-associated macrophage protein 1, Nramp1)
[23], which has been suggested to be a pH-dependent divalent cation efflux pump at
the phagosomal membrane of macrophages (for a review see [24]). In phagocytes
the Slc11a1 protein has been implicated in acidification and maturation processes
of the phagosome, which are important for intracellular, bactericidal host defense.
Screening the responses of mice to bacterial products instead of using living
pathogens can also reveal host factors involved in pathogen resistance. Variation in
inflammatory responses in inbred strains of mice after challenge with purified
lipopolysaccharide (LPS) had already been found 40 years ago (for review see [25]).
LPS is an abundant glycolipid present in the outer membrane of Gram-negative
bacteria, which can provoke generalized, inflammatory responses in the infected
host. Hyporesponsiveness to LPS can render mice highly susceptible to Gram-
negative infections with pathogens such as Salmonella and Klebsiella because mac-
rophage activation is impaired. Defects in LPS signaling in C3H/HeJ and C57BL/
10ScN mice were found to be under control of the Lps locus on mouse chromosome
4. This locus was identified as the Toll-like receptor 4 gene and the positional cloning
of Lps first demonstrated that mutations in this class of pathogen-recognition re-
ceptors can profoundly affect susceptibility to infectious agents [26, 27]. The Toll-
like receptor (TLR) gene family now comprises 11 members in mice (Tlr1-Tlr11,
[28]) and is one of the best-studied immune sensors for invading pathogens. The
signaling pathways triggered after recognition of pathogen-associated molecular pat-
terns (PAMPs), which are the evolutionary conserved products of microbial metabo-
lism initiate innate immunity and help to strengthen adaptive immune responses.
Several important Tlr-adaptor molecules and downstream Tlr-pathway regulator
proteins were identified through N-ethyl-N-nitrosourea (ENU)-mutagenesis
screens in mice [29] or via gene targeting approaches and the subsequent phenotyp-
ing of PAMP responses in Tlr-deficient mice (for reviews see [30, 31]). In addition,
other PAMP recognition receptors such as the Cd36 molecule were linked with hy-
persusceptibility to Gram-positive pathogens (e. g. Staphylococcus aureus) using
ENU mutagenesis approaches in the mouse [32]. Here, the laboratory of Bruce
Beutler at the Scripps Institute in San Diego has played a pivotal role in establishing
specialized ENU mutagenesis screens in mice which allow the systematic genetic
investigation of the mouse immune and host defense system [29, 32, 33].
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Within the last few years many valuable new techniques have been developed for
phenotyping immune responses in infectedmice. In particular,manynewnon-inva-
sive techniques have been designed to image host defense responses in mice. These
are very interesting developments because they have the potential for infection
phenotyping of mice in high-throughput primary screens. Currently, the characteri-
zation of infection susceptibility is very laborious, time consuming, and usually re-
quires many animals to monitor the kinetics of pathogen dissemination and to ex-
amine the organ pathology of the mice after infection. With new diagnostic tools in
imaging this might change in the future. Such efforts need support because non-in-
vasive imaging techniques will be crucial tools for experimental pharmacological re-
search and antimicrobial drug development. Examples of modern imaging tech-
nologies are two-photon microscopy [34], magnetic resonance imaging (MRI) [35],
and in vivo bioluminescence imaging of pathogen dissemination in the entire body
of an infected mouse over time with sensitive charge-coupled device (CCD) cameras
[36, 37]. Another interesting new imaging technique is the in vivo reporter enzyme
assay which uses radiolabeled substrates that allow the in situ detection of pathogens
with single-photon emission computed tomography (SPECT) [38].
A very important method for monitoring the induction and maintenance of T-cell
responses to infectious agents is the tetramer staining technique which facilitates
investigation of the function of T cells in recall infection experiments [39, 40]. Most
T cells recognize peptides derived from pathogens that are bound to MHC
molecules on the surface of target cells or antigen-presenting cells (APCs). This rec-
ognition is specific for both the MHC allele and the pathogen-derived peptide. Flow
cytometry can be used to detect soluble peptide−MHC complexes attached to
fluorochromes thus making it possible to identify antigen-specific T cells. However,
due to the poor binding of monomeric peptide−MHC complexes to the T cell recep-
tor, the use of multimers which are typically tetramers, is required. For staining, the
purified MHC molecules are biotinylated and then added to fluorescently-labeled
streptavidin complexes in solution. The tetramer staining technique was essential
to study for example, the transition from primary effector T cell to memory T cell
responses after L. monocytogenes infection [41] and for the characterization of
CD8+ T cell responses to this pathogen [42].
8.3
The Impact of Mouse Genetics on the Understanding of Human Infectious Diseases
Primary immunodeficiency diseases in humans consist of a group of more than
100 inherited clinical manifestations that can predispose individuals to different in-
fectious diseases, allergy, autoimmunity and cancer [43]. Many of the identified
genes that have been associated with abnormal or deficient immune responses in
patients had been identified before using the mouse as a model system (see also
Chapter 10 of this volume). Mutations in genes that lead to primary immunodefi-
ciencies are often associated with recurrent infections in patients that are caused by
very diverse microorganisms. A good example of such a generalized immunodefi-
ciency is chronic granulomatous disease (CGD), which is characterized by frequent
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infections with pathogens such as Staphylococcus aureus, Aspergillus fumigatus,
Salmonella (non-typhoid serovars), Serratia marcescens and Burkholderia cepacia (for
a review see [44]). CGD can be caused by inherited mutations in genes that encode
the gp91-phox, p47-phox, p22-phox or p67-phox subunits of the NADPH-
dependent phagocyte oxidase (for a review see OMIM database
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM and [44]). Murine mod-
els of CGD that lack functional Cybb (gp91phox; [45]) or Ncf1 (gp47phox; [46]) alleles,
recapitulate the immune defects that are observed in man and can be considered as
geno- and phenocopies of the human disease.
Mutations and disease-associated polymorphisms in TLR-pathway genes or in
the TLR-encoding genes that are themselves responsible for the predisposition of
patients to infectious diseases, have also been identified. This was achieved through
the extensive work that had previously been carried out in mice to unravel the un-
derlying mechanisms of host defense. A dominant TLR5 stop codon mutation that
abolishes the recognition of bacterial flagellin could be linked to susceptibility to
Legionnaires’ disease. This was confirmed after a large outbreak of the disease at a
flower show in the Netherlands in 1999 by the subsequent screening of affected in-
dividuals for sequence variants in the TLR5 gene [47, 48]. TLR5 was a candidate
gene because the molecular and functional characterization of this receptor had
previously been established using knockout mice [49]. Other examples of mutated
human genes that are involved in TLR signaling are deficiencies in IRAK4 which
cause hyporesponsiveness to LPS and a predisposition to pyogenic bacterial infec-
tions [50, 51] and variations in the TLR4 sequence that may be linked to the develop-
ment of meningococcal sepsis in patients [52] and to resistance to Legionnaires’ dis-
ease [53].
Mendelian susceptibility to mycobacterial diseases (MSMD) is a rare syndrome
of severe infections caused by low-virulence mycobacteria and Salmonella in
patients carrying mutations in five genes of the IL-12-IFN-γ-STAT1 signaling axis.
Interestingly, these patients seem to be resistant to other pathogens, while knock-
out mice with deficiencies in the homologous genes are widely susceptible to many
different microorganisms (for a detailed review see [54]).
Since the early studies of Emil Skamene on complement factor C5 deficiency in
mice and their susceptibility to Listeria infections, it would seem that the comple-
ment-activation product C5a in particular, may be associated with the development
of sepsis in humans (see the recent detailed review by Peter Ward [55]).
The mouse has been instrumental in accelerating the advances in immunologi-
cal research which have been made in recent decades [56, 57]. However, it must be
remembered that discoveries made using mice do not necessarily lead to corre-
sponding insights in humans. Different selection pressures (many caused by para-
sites and pathogens) over the last 65 million years of evolution have left their im-
prints on the human and rodent genomes. These are also responsible for the differ-
ences between mouse and human immunology [58]. Nevertheless, mice will re-
main the prime experimental model of choice for immunological research and de-
fined differences in host defense genes between both organisms might be tackled
in the future by directed transgenic approaches (e. g. humanization of mice
through “knock in” procedures or replacement with human genes).
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8.4
Phenotyping at the GBF-Mouse Infection Challenge Platform (ICP)
At our research institution we are working primarily with three bacterial pathogens
to characterize the innate and adaptive immune responses of mice. The infection
experiments are performed under controlled “SPF” conditions (see also Sec-
tion 8.5.4). Mice are housed in individually ventilated cages (IVCs) and are handled
only in protected areas (under laminar flow hoods). All material, which is brought
into the animal infection unit, is either autoclaved or sterilized with H2O2. An ex-
tensive sentinel program is used to screen the unit every 3 months for the presence
of unwanted microorganisms. New mouse strains from external sources are im-
ported into the facility via embryo transfer. In addition, the “altered Schaedler flora
(ASF)” is used to colonize the gastrointestinal tracts of transferred mice with a de-
fined microflora [59]. To accomplish this, germ-free foster mice that have previously
been colonized with the ASF are used for embryo transfers.
We use Streptococcus pyogenes as an extracellular, Gram-positive pathogen to inves-
tigate cellular mechanisms and molecules that are linked to the induction of
bacteremia and sepsis [60].Within the last few years, this infectionmodel has proven
very useful in the elucidation of immune mechanisms underlying disease suscepti-
bility to streptococcal-induced sepsis in the mouse (for more information see [61]).
To investigate mucosal immune responses to pathogenic Gram-negative bacteria
in the gut we established a low-virulence infection model with Yersinia enterocolitica.
Here, the strain Y. enterocolitica E40 serotype O:9 is employed to specifically analyze
responses to local infection in the intestine and Peyer’s patches. Mice are infected
withY. enterocoliticaby thenatural route (oral) and immune responses aremonitored
at 3, 9, and 21 days after infection. The model is very informative but also quite labor
intensive because it involves histology as one of themajor out-read-systems for infec-
tion susceptibility and resistance (Frischmann,U. andMüller,W. in preparation). Its
main advantage over othermouse infectionmodels is that the presence of infectious
lesions and the influx of various immune effector cells after infection can be moni-
tored effectively at very high resolution (e. g. the cellular level). To test new mutant
lines of mice for general defects in host defense we use the intracellular pathogen
Listeria monocytogenes, which has been mentioned above. The screening protocols
used for this pathogen will be listed below. Additional infection protocols for the
other ICP-pathogens, S. pyogenes andY. enterocolitica can be accessed at the EUMOR-
PHIA website (http://www.eumorphia.org). Within the last 3 years we have estab-
lished standardized operation procedures (SOPs) for infection phenotyping of mice
in the framework of EUMORPHIA that can be used for reference. In addition to the
SOPs for mouse infection challenge with S. pyogenes, L. monocytogenes, and Y. entero-
colitica, other associated documents and primary-extended screens for macrophages
(e. g. PAMP responses) can be found on this website.
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8.4.1
Sreening Protocols
8.4.1.1 Infection with Listeria monocytogenes
The mouse model of L. monocytogenes infection has been used extensively to investi-
gate immune responses to bacterial infection [16]. The response of the mouse to L.
monocytogenes infection can be divided into an early non-specific inflammatory re-
sponse, which is initiated after recognition of the pathogen by the innate immune
system, and a more delayed specific immune response which is mediated by the
adaptive immune system (Fig. 8.1). L. monocytogenes can be administered through
different routes of infection. Inoculation of L. monocytogenes into mice can be car-
ried out orally, intraperitoneally (i. p.), subcutaneously (s.q.) or intravenously (i. v.).
However, although infecting mice orally is the natural route of infection for L. mon-
ocytogenes, high doses of the bacterium are required for the successful establish-
ment of a systemic infection. This is thought to be due to the species-specific inter-
action of the Listeria protein internalin A on the surface of the bacterium with its
host cell receptor E-cadherin [62]. The interaction of both proteins mediates the ad-
hesion and invasion of Listeria into the epithelial cells of the intestine. Humans and
mice have a different amino-acid residue at a critical site in the E-cadherin protein
[63]. It has been suggested that this difference in E-cadherin is responsible for the
host-specific tropism of Listeria in the gut. In our laboratory we use the intravenous
route of infection. This inoculation method is highly reproducible and results in a
rapid systemic infection. Different strains of L. monocytogenes can vary in virulence.
For our infection protocols we use the L. monocytogenes strain EGD, which is com-
monly used for phenotyping and has an intermediate to high virulence in mice
when compared to other available strains of Listeria [64]. The advantage of this
strain is that a European consortium has sequenced its genome [65] and many iso-
genic L. monocytogenes mutants are available in this genetic background. This al-
lows the use of bacterial mutants, which are attenuated in virulence due to the defi-
ciency of critical virulence factors. Therefore, these Listeria mutants can be used to
phenotype the host response of very susceptible mouse mutant strains that would
otherwise immediately succumb to the infection (for instance, interferon-γ gene
knockout mice). In general infection doses ranging from 102 (sublethal) to
105 colony forming units (cfu) are used, depending on the LD50 of the mouse strain
under investigation. As already mentioned, the most commonly used inbred
mouse strains differ significantly in their susceptibility to Listeria infection [17].
Therefore, it is advisable to test the LD50 of a particular mouse mutant strain before
starting extensive experiments, especially when the mouse strain under investiga-
tion is maintained on a mixed genetic background. Together with the laboratory of
Dirk Busch at the German Mouse Clinic (see also Chapter 10 in this volume) we
have recently established extensive baseline data sets for the C57BL/6J, C3H/HeN,
BALB/c and CBA/J inbred mouse strains that can be used for reference [66]. In the
course of this project we made the interesting observation that infection of mice
with L. monocytogenes is associated with a sex-dependent susceptibility pattern. In-
dependent of the genetic background, female mice are in general more susceptible
to the infection than male mice [66] and this should also be taken into account
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when undertaking infection challenge experiments with this pathogen. Following
i. v. infection of mice, L. monocytogenes is first confronted by macrophages and
neutrophils in the spleen and the liver. Within the next 6−12 h of infection 60 to
90% of the bacteria are killed and the organism can no longer be detected in the pe-
ripheral blood of immunocompetent mice. The early pro-inflammatory response in
the liver is initiated by the interaction of the pathogen or its products with pattern
recognition receptors (e. g. Tlr2 and Tlr5) on the surface of Kuppfer cells [67], which
are the macrophages of the liver. The interaction of the bacterial PAMPs with TLRs
induces signal transduction pathways that lead to the activation of transcription fac-
tors (e. g. NF-κB), which in turn promotes the production and release of pro-inflam-
matory cytokines involved in innate host defense mechanisms (e. g. IL-1, IL-6 and
TNF-α). These events promote the accumulation of neutrophils at the local infec-
tion sites. These immune effector cells are the principal microbicidal population in
the liver during the first 24 to 48 h of Listeria infection [68]. They eradicate most of
the bacteria and produce additional cytokines and chemokines that attract and
further stimulate additional immune effector cells, such as monocytes, granulo-
cytes, natural killer (NK) cells and T cells. The cytokine IFN-γ which is mainly pro-
duced by NK cells and T cells of the T-helper cell type-1 type (Th1), in turn activates
macrophages that phagocytose and kill the pathogen inside the infected tissue.
These responses substantially reduce the infectious burden of the animal and are
essential for the survival of the infected mice. If these initial host reactions fail, the
mice will eventually die within the first 2−3 days after infection. In these cases, his-
topathological analysis will reveal necrotic, multifocal granuloma in the liver and
spleen and necrotic lesions caused by multiplying Listeria in the bone marrow
(Fig. 8.2). During the normal infection process in an immunocompetent host, a
fraction of the L. monocytogenes taken up by the liver escapes the antimicrobial activ-
ity of neutrophils and macrophages and will spread to hepatocytes, in which the
bacteria will further replicate intracellularly. In immunocompetent mice, T cells
will finally mediate the clearance of the pathogen and will eventually provide long-
term immunity. This specific immune response to the pathogen occurs 5 to 7 days
after infection and is mainly mediated by cytolytic CD8+ T cells (for a review see
[69]). If these T cell-mediated adaptive immune responses fail the mice will die
from the infection 7 to 10 days after inoculation. To test T cell immunity specifically
to Listeria monocytogenes we recommend the recall infection experiments described
in Chapter 10 of this volume.
When live Listeria are used for infection challenge experiments in mice, it should
be remembered that the bacteria are pathogenic organisms that can cause severe,
sometimes lethal infections in immunocompromised patients or in individuals re-
ceiving immunosuppressive drugs. Therefore, all work carried out using L. monocy-
togenes must be performed under Biosafety Level 2 (BL-2) conditions. Investigators,
who decide to work with this pathogen, should consult their local Biological Safety
Department for guidance and approval prior to planning any experiments. If stand-
ard precautions are observed and followed, work with this microorganism can be
carried out quite safely. The fact that detailed microbial and immunological charac-
terization has been carried out on L. monocytogenes, makes it one of the safest and
most popular pathogens to be used in experimental immunology worldwide.
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 Fig. 8.1 Early innate and delayed specific host
immune responses to Listeria monocytogenes
in the liver. Important effector cells involved in
the immune response and released cytokines
and chemokines are shown (PMNs, polymor-
phonuclear neutrophils; NK, natural killer
cells). Cytolytic CD8-T cells which are involved
in the specific immune response to L. mono-
cytogenes kill infected hepatocytes through in-
duction of apoptosis via the FAS ligand
(FasL)/FAS receptor pathway or the perforin
and granzyme pathway.
Fig. 8.2 Histopathological analysis of Listeria
monocytogenes infections in mice. (a) Trans-
verse section of the bone marrow from a CBA/
J male 3 days after infections (L. monocyto-
genes EGD, 1 × 104 cfu , i. v.). (b) Transverse
bone marrow section of a CBA/J female
3 days after infection with the same infection
dose as in (a); note in (b) in comparison to
(a) the acute and focal necrosis in the epiphy-
sis of the bone marrow (indicated by stars).
Female mice are more susceptible to L. mono-
cytogenes infection than male mice. Sections
in (a) and (b) were stained with hematoxylin
and eosin. (c) Bone marrow section from the
female shown in (b) stained with an anti-Lis-
teria antibody. Bacteria are multiplying in the
bone marrow at the sites of cellular necrosis
(brown color). (d) Transverse liver section of a
CBA/J female 1 day after i. v. infection with
1 × 104 cfu L. monocytogenes EGD. Granulo-
matous hepatitis with central necrosis and in-
filtration of neutrophilic granulocytes are vis-
ible. Scale bars = 12.5 μm.
8.4 Phenotyping at the GBF-Mouse Infection Challenge Platform (ICP)
212
8.5
Practical Guidelines
8.5.1
Growing Log-phase Cultures of Listeria monocytogenes EGD for Mouse Infection
Reagents Phosphate buffered saline (PBS) pH 7.0, Brain Heart Infusion Medium
(BHI from Becton and Dickinson, MD, USA; dissolve 37 g BHI powder in 1 l H2O,
autoclave and store at 4 °C), BHI plates (add 15 g agar to 1000 ml BHI medium,
autoclave, pour plates and store at 4 °C for a maximum of 4 weeks), 0.4% Trypan
blue (dilute 400 mg Trypan blue (Sigma) in 100 ml H2O, sterile filter (0.22 μm) and
store at room temperature.
Equipment Laboratory centrifuge (with temperature control), incubator set at
37 °C, shaking incubator (37 °C, 110 r.p.m.), photometer set at a wavelength of
600 nm, microscope (upright, no inverse) with 10 × ocular and 20 × (brightfield)
and 40 × (phase contrast) objectives and phase contrast condenser, Thoma chamber
(normal chamber depth, 0.1 mm), laminar-flow bench (BL2 level).
Procedure
1. Day 1: plate Listeria from a fresh glycerol stock on a pre-warmed (37 °C) BHI
plate. Let bacteria grow for 24 h at 37 °C.
2.Day 2: inoculate a single colony from the BHI plate into 6 ml of BHI medium in a
14-ml snap cap tube. Let bacteria grow overnight at 37 °C in a shaking incubator
(110 r.p.m.).
3. Day 3: measure OD600 of the overnight culture, OD should be around 1.0. Dilute
overnight culture 1 : 10 in BHI medium (3 ml bacteria in 27 ml BHI) in an Erlen-
meyer flask. Measure OD600 of the dilution. Let the bacteria grow at 37 °C in a
shaking incubator (110 r.p.m.).
4. After 2 h of growth start to measure OD600 in 5−10-min intervals until an OD600 of
0.5 is reached. Centrifuge bacteria for 5 min at 1600 g, 4 °C. Pour off the super-
natant and add 10 ml of ice-cold PBS. Re-suspend the pellet carefully using a pi-
pette. Centrifuge for 5 min at 1600 g, 4 °C. Pour off the supernatant and re-sus-
pend the pellet in 25 ml of ice-cold PBS. Dilute 100 μl of bacteria in 900 μl of
0.4% Trypan blue. Count the cells under a microscope using a Thoma chamber.
Dilute Listeria to a concentration of 1 × 106 cfu/ml in PBS.
5. Prepare 10−1, 10−2, 10−3, 10−4 dilutions of the Listeria using PBS. Plate 100 μl of
the 10−2, 10−3 and 10−4 dilution on BHI plates, each on three separate plates. In-
cubate overnight at 37 °C. Count the colonies on the following day and calculate
the concentration of Listeria inoculum (cfu) used in the experiment.
8.5.2
Infection of Mice with Listeria monocytogenes EGD
Reagents Phosphate buffered saline (PBS), pH 7.0.
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Equipment Infrared light (e. g. Philips Infrared PAR-38, 150 W), mouse strainer
(e. g. Plas-Labs, #551-BSSR), syringe with 29 G needle (e. g. B.Braun Omnican®-F),
Laminar-flow bench (BL2 level).
Procedure
1. Use the L. monocytogenes inoculum prepared from the protocol above. Dilute
bacteria to 1.5 × 105 cfu/ml in PBS. An injection of 100 μl is equivalent to an in-
fection dose of 1.5 × 104 cfu per mouse which is the LD50 for female C57BL/6J
mice. If the mouse strain of interest is more susceptible or resistant in an ini-
tial experiment, repeat the infection procedure using a lower or higher dose re-
spectively.
2. In a laminar flow hood open the animal cage under infrared light for at least
2 min. The distance between the top of the cage and the bulb should be approxi-
mately 20 cm.
3. Pre-warm mice individually by placing each mouse on top of the cage under the
bulb for 15−30 s. Place the mouse in a mouse restraining device.
4. Inoculate 100 μl diluted L. monocytogenes into the lateral tail vein (veins are visible
on both sides of a pre-warmed mouse tail). Start injecting near the tip of the tail.
5. Survival rates can then be determined with a daily health check of the infected an-
imals for a period of 14 days (for more detailed instructions see “SOP Health
monitoring of mice in infection experiments”, Workpackage 6 accessible at
http://www.eumorphia.org, or upon request). Animals that survive for 14 days
are ranked as “resistant”.
8.5.3
Quantification of Bacterial Growth in Spleen and Liver after L. monocytogenes
Infection
Reagents Phosphate buffered saline (PBS) pH 7.0, Brain Heart Infusion Medium
(BHI from Becton and Dickinson, MD, USA; dissolve 37 g BHI powder in 1 l H2O,
autoclave and store at 4 °C), BHI plates (add 15 g agar to 1000 ml BHI medium,
autoclave, pour plates and store at 4 °C for a maximum of 4 weeks).
Equipment Laboratory centrifuge (with temperature control), incubator set at
37 °C, automated tissue homogenizer, Laminar-flow bench (BL2-level).
Procedure
1. Sacrifice mice by cervical dislocation on day 2 or 3 after infection (depending on
the survival curve of the previous experiment; use time points prior to the deaths
of the first mice).
2. Aseptically remove liver and spleen. Weigh all organs and put in a 14-ml Snap
cap tube containing 5 ml pre-cooled (4 °C) PBS. Store all organs on ice until all
mice have been sacrificed and dissected.
3.Homogenize tissues for 30 s using an automatic homogenizer. Clean out homo-
genizer between two samples by squirreling with PBS (2 × 5 s), 70% ethanol
(1 × 5 s) and PBS (1 × 5 s).
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4.Prepare dilutions of tissue homogenates (10−1, 10−2, 10−3, 10−4, and 10−5 dilutions)
using PBS and snap cap tubes. Plate dilutions onto BHI plates in triplicate. Store
dilutions at 4 °C for further dilutions (if necessary).
5. Next day, count colonies and calculate total cfu/organ and cfu/mg organ. If the
10−5-dilution plates are still overgrown, prepare further dilutions (10−6, 10−7, and
10−8) and plate again in triplicate.
8.5.4
Troubleshooting
Critical parameters for infection challenge experiments and immunological pheno-
typing are as follows:
 “Specific pathogen free” (SPF) housing conditions for mice. Background infec-
tions can severely alter the immune status of mice and can therefore have a deep
impact on the outcome of infection experiments [70]. In our mouse facility we
follow the recommendations of the Federation of European Laboratory Animal
Science Association (FELASA) to maintain standardized hygiene conditions [71].
 Standardization of experiments and inclusion of internal controls. For infection
experiments age- and sex-matched animals should be used. To control for in-
oculum quality and technical effectiveness of infection we use mice from known
susceptible inbred strains as internal controls. These are infected together with
the experimental group of mice and the results in this control group should
match the previously recorded baseline data for this particular strain.
 It is advisable to use standardized microbiology laboratory practice to exclude
contamination of bacterial stocks, inoculum, and experimental samples. Protec-
tive clothing should be worn when handling and manipulating bacteria,
samples and animals and all procedures should be carried out in a laminar-flow
hood.
8.6
Outlook
The identification and characterization of infectious disease loci in mice cannot be
successfully accomplished without in vivo infection experiments combined with
sophisticated and detailed phenotypic analysis. To further investigate the molecular
and cellular mechanisms of host−pathogen interactions in the future there is a
need to extend the currently available genetic toolbox for the mouse. We need to es-
tablish new transgenic mouse lines that allow a spatial and temporal depletion of
critical immune effector cells during the host defense response. For example, con-
ditional expression of cholera toxin could be used to specifically deplete the im-
mune system of cells of the myeloid or lymphoid cell lineage. This would help to
characterize the contributions of specialized or activated cells (such as different
types of macrophages) to the host defense response.
We also need to further miniaturize the readout assays and systems that are
used to monitor the host response in a non-invasive manner. New advances in
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proteomics technology should be combined with immunology. The new emerg-
ing field of “immunoproteomics” is very promising in this respect [72, 73]. New
techniques should help to identify novel surrogate markers of immune responses
that can subsequently be used to establish new high-throughput diagnostic tools
(e. g. antibody arrays for the detection of antigen-specific immunoglobulins or
new acute-phase serum proteins). New imaging technologies will definitely have
a deep impact on the phenotyping of infection responses. They will elucidate the
complexity and dynamics of infection processes in vivo without disturbing or in-
terfering with the integrity of the different host immune compartments that are
involved in defense mechanisms against pathogens. Some examples of emerging
new imaging technologies have already been mentioned in this chapter and in
Chapter 10.
The challenge of the future is to identify and understand the diverse intersection
points where pathogen virulence factors interfere with host defense and metabo-
lism. Systems biology approaches combined with new quantitative readout assays
for “immunophenotypes” might be the key to understanding regulatory and signal-
ing networks that are most critical for defense against pathogens and drug develop-
ment.
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